Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cysteinyl leukotriene receptor 2 | Starlite/ChEMBL | No references |
Homo sapiens | cysteinyl leukotriene receptor 1 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | P2X receptor subunit | 0.0213 | 1 | 1 |
Schistosoma mansoni | inosine-5-monophosphate dehydrogenase | 0.0087 | 0.2645 | 0.1146 |
Trypanosoma cruzi | inosine-5'-monophosphate dehydrogenase, putative | 0.0087 | 0.2645 | 0.5 |
Mycobacterium leprae | Probable inosine-5'-monophosphate dehydrogenase GuaB3 (IMP dehydrogenase 2) (inosinic acid dehydrogenase) (inosinate dehydrogena | 0.0045 | 0.0252 | 0.0954 |
Plasmodium vivax | inosine-5'-monophosphate dehydrogenase, putative | 0.0081 | 0.2346 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | IMP dehydrogenase | 0.0087 | 0.2645 | 0.5 |
Mycobacterium leprae | Probable inosine-5'-monophosphate dehydrogenase GuaB2 (IMP dehydrogenase) (IMPDH) (IMPD) | 0.0087 | 0.2645 | 1 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.0213 | 1 | 1 |
Schistosoma mansoni | P2X receptor subunit | 0.0213 | 1 | 1 |
Toxoplasma gondii | IMP dehydrogenas | 0.0087 | 0.2645 | 0.5 |
Mycobacterium tuberculosis | Probable inosine-5'-monophosphate dehydrogenase GuaB2 (imp dehydrogenase) (inosinic acid dehydrogenase) (inosinate dehydrogenase | 0.0087 | 0.2645 | 1 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.0213 | 1 | 1 |
Trypanosoma cruzi | inosine-5'-monophosphate dehydrogenase, putative | 0.0087 | 0.2645 | 0.5 |
Trypanosoma cruzi | GMP reductase | 0.0087 | 0.2645 | 0.5 |
Mycobacterium ulcerans | inosine 5'-monophosphate dehydrogenase | 0.0087 | 0.2645 | 1 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.0213 | 1 | 1 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.0213 | 1 | 1 |
Trypanosoma brucei | GMP reductase | 0.0087 | 0.2645 | 0.5 |
Trypanosoma cruzi | inosine-5'-monophosphate dehydrogenase, putative | 0.0087 | 0.2645 | 0.5 |
Brugia malayi | inosine-5'-monophosphate dehydrogenase family protein | 0.0087 | 0.2645 | 0.5 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.0213 | 1 | 1 |
Leishmania major | inosine-5-monophosphate dehydrogenase | 0.0087 | 0.2645 | 0.5 |
Plasmodium falciparum | inosine-5'-monophosphate dehydrogenase | 0.0081 | 0.2346 | 0.5 |
Leishmania major | guanosine monophosphate reductase | 0.0087 | 0.2645 | 0.5 |
Trypanosoma cruzi | GMP reductase | 0.0087 | 0.2645 | 0.5 |
Loa Loa (eye worm) | IMP dehydrogenase 1 | 0.0087 | 0.2645 | 0.5 |
Mycobacterium ulcerans | inosine 5-monophosphate dehydrogenase | 0.0081 | 0.2346 | 0.8869 |
Trypanosoma brucei | inosine-5'-monophosphate dehydrogenase | 0.0087 | 0.2645 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.42 nM | Inhibition of binding of [3H]-LTD4 to guinea pig lung membrane | ChEMBL. | No reference |
IC50 (binding) | = 0.42 nM | Inhibition of binding of [3H]-LTD4 to guinea pig lung membrane | ChEMBL. | No reference |
IC50 (binding) | = 2.01 nM | Inhibition of binding of [ H]-LTD4 to DMSO differentiated U937 cell membranes | ChEMBL. | No reference |
IC50 (binding) | = 2.01 nM | Inhibition of binding of [ H]-LTD4 to DMSO differentiated U937 cell membranes | ChEMBL. | No reference |
IC50 (binding) | = 2.2 nM | Inhibition of binding of [3H]-LTD4 to guinea pig lung membrane supplemented with 0.05% human serum albumin(HSA) | ChEMBL. | No reference |
IC50 (binding) | = 2.2 nM | Inhibition of binding of [3H]-LTD4 to guinea pig lung membrane supplemented with 0.05% human serum albumin(HSA) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.